Exchange: NYSE·Updated 06:59 PM EST

COR News

News
all
press releases
Barclays Issues Positive Forecast for Cencora (NYSE:COR) Stock Price
Barclays increased their price target on shares of Cencora from $350.00 to $415.00 and gave the stock an "overweight" rating in a report on Wednesday...
MarketBeat
Barclays Issues Positive Forecast for Cencora (NYSE:COR) Stock Price
Barclays increased their price target on shares of Cencora from $350.00 to $415.00 and gave the stock an "overweight" rating in a report on Wednesday...
MarketBeat
More News
Cencora's specialty pharma expansion, strategic acquisitions and logistics growth support its prospects, despite pricing pressures and fiscal 2027 headwinds
Zacks
Wells Fargo & Company increased their target price on Cencora from $395.00 to $400.00 and gave the stock an "overweight" rating in a research note on Tuesday...
MarketBeat
Mawer Investment Management Ltd. trimmed its position in shares of Cencora, Inc. (NYSE:COR - Free Report) by 7.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,375,606 shares of the company's stock after...
MarketBeat
(RTTNews) - The U.S. Federal Trade Commission or FTC announced that it has filed a lawsuit to block Covetrus Inc. and its owners, Clayton, Dubilier & Rice LLC and TPG Inc., from acquiring MWI Veterinary Supply Inc. from Cencora Inc. (COR) in a deal valued at $3.5 billion...
Nasdaq News: Markets
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 7.95% on an annualized basis producing an average annual return of 20.98%. Currently, Cencora has a market capitalization of $64.82 billion.read more...
Benzinga
BDX, COR and UNF recently hiked dividends, offering investors steady income opportunities as market volatility, inflation and economic uncertainty persist.
Zacks
COR's Q4 earnings and revenues beat estimates as specialty drug demand fuels growth and margins expand. The company raises its fiscal 2027 outlook.
Zacks
Cencora (NYSE:COR) reported fourth-quarter financial results on Wednesday. The transcript from the company's fourth-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...
Benzinga
Although the revenue and EPS for Cencora (COR) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks

Advertisement|Remove ads.